Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Use of Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC

NCT00338455 is registered in ClinicalTrials.gov with Scios, Inc. as lead sponsor.

NCT NCT00338455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00338455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Use of Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC
Lead sponsor
Scios, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2006
Completion date
October 31, 2007
Enrollment
16 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac transplantation, congestive heart failure, renal failure, renal insufficiency